| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.2M | -1.5% | +27.6% |
| Cost of Revenue | $5.0M | +3.5% | +58.8% |
| Gross Profit | $2.2M | -11.3% | -12.0% |
| R&D Expense | $298K | +10.9% | +27.4% |
| SG&A Expense | $3.4M | +10.4% | +27.2% |
| Operating Income | -$2.1M | -48.8% | -140.6% |
| Pre-tax Income | -$2.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.3M | +829.6% | +1089.6% |
| Accounts Receivable | $6.2M | -6.3% | +14.2% |
| Inventory | $9.6M | -1.3% | -3.4% |
| Current Assets | $32.1M | +68.5% | +76.6% |
| Total Assets | $41.5M | +46.2% | +50.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.3M | — | — |
| Capital Expenditures | $353K | — | — |
| Investing Cash Flow | -$395K | — | — |
| Financing Cash Flow | $17.6M | — | — |
| Free Cash Flow | -$7.7M | — | — |
| -45.3% |
| -136.2% |
| Net Income | -$2.1M | -45.5% | -129.0% |
| EPS (Basic) | -$0.07 | -16.7% | -75.0% |
| EPS (Diluted) | -$0.07 | -16.7% | -75.0% |
| $11.8M |
| -15.4% |
| -0.2% |
| Total Liabilities | $16.1M | -16.8% | -0.9% |
| Stockholders' Equity | $25.5M | +179.8% | +125.2% |